title: Refractory metastatic thyroid cancer: is Doxorubicin still a valid treatment option?
authors.forename: Constantin A
authors.initials: CA
authors.lastname: Dasanu
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002291:Carcinoma, Papillary / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D004317:Doxorubicin / Q000627:therapeutic use*; D005260:Female; D006254:Hawaii / Q000208:ethnology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D008875:Middle Aged; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin